Searchable abstracts of presentations at key conferences in endocrinology

ea0015p46 | Clinical practice/governance and case reports | SFEBES2008

Use of glitazones in type 2 diabetes

Rajeev Surya Panicker , Nair Satheesh Balakrishnan , Mahmoud Mohammed , Baglioni Piero

Aim: To compare the use of glitazones against NICE guidelines. (Glitazone recommended as second line therapy in combination with metformin or sulfonyl urea in patients with intolerance or contra-indications to any of the two, not as monotherpay or triple therapy or in combination with insulin).Methods: Patients on glitazone therapy (n=60) were randomly identified from a pharmacy data base from August to December 2006. Retrospective case note revie...